Ex-Pharmacist, Technician From Three Notch Pharmacy Accused of Diverting Opioids in Federal Indictment
A federal grand jury in Mobile has charged a former Three Notch Pharmacy pharmacist and technician with acquiring opioids by fraud and deception, and accuses the pharmacist of faking inventory counts to hide the losses.
MOBILE, Ala. — A pharmacist and a pharmacy technician who once worked at Three Notch Pharmacy are now facing federal charges, accused of using their positions to take prescription opioids and, in the pharmacist’s case, of doctoring inventory records to hide the losses.
A grand jury in the U.S. District Court for the Southern District of Alabama returned the indictment against James Andrew Kruse and Lisa Kay Norris, and it was filed Nov. 18. Both are charged with offenses involving controlled substances. An indictment is a formal accusation, not a finding of guilt, and both defendants are presumed innocent unless proven guilty in court.
The Charges at a Glance
- James Andrew Kruse: Accused of acquiring hydrocodone and oxycodone by fraud and of creating false pharmacy inventory records. Prosecutors say the conduct ran from January to December 2024.
- Lisa Kay Norris: Accused of acquiring oxycodone and hydrocodone by deception. Prosecutors say she hid pills while she was filling prescriptions in order to misstate how many had been dispensed.
- Court: U.S. District Court, Southern District of Alabama
- Filed: Nov. 18, 2026
What Prosecutors Allege
The government’s case against Kruse centers on the pharmacy’s books. According to the indictment, over the course of 2024 he changed pill counts and produced inventory records that were not accurate, with the goal of covering up the fact that narcotics were being diverted from the store’s stock. The two drugs named in his charges, hydrocodone and oxycodone, are among the most tightly controlled medications a pharmacy handles.
The allegations against Norris describe a different method. Prosecutors say that as she filled prescriptions, she kept some pills out of sight so the pharmacy’s records would show that more medication had gone into a prescription than actually did. She is likewise charged in connection with oxycodone and hydrocodone.
The information released so far does not explain how investigators first learned of the alleged conduct or how many pills may have been involved.
A Separate State Licensing Case
The federal case follows earlier action by Alabama’s pharmacy regulators. Kruse voluntarily surrendered his pharmacist license in December 2024, at the end of the period covered by the indictment.
In August 2025, the Alabama Board of Pharmacy issued an order finding him guilty of violating state pharmacy law. According to that order, Kruse acknowledged to the board that he had taken controlled medications out of the store’s supply for unauthorized use. Regulators listed the diverted drugs as Norco, oxycodone, Xanax and Adderall. Norco is a brand-name combination of hydrocodone and acetaminophen; Xanax is the anti-anxiety drug alprazolam; and Adderall is a stimulant prescribed for attention-deficit/hyperactivity disorder.
The board suspended his license, but the suspension immediately converted to seven years of probation. The board also fined him $4,000. Its order noted that Kruse had gone through inpatient treatment for addiction and intended to follow an aftercare plan.
As for Norris, the board’s online license verification system shows her registration as a pharmacy technician has been surrendered. The lookup lists no public records for her.
State licensing proceedings and federal criminal cases are separate. A licensing board’s job is to protect the public by deciding who may practice a regulated profession, and its findings are not a criminal conviction. The federal charges will be decided on their own in court.
Why Pharmacy Records Are So Closely Watched
Hydrocodone and oxycodone are classified under federal law as Schedule II controlled substances, meaning they have accepted medical uses but a high potential for abuse and dependence. Adderall is also in Schedule II, while Xanax is in Schedule IV.
Because of those classifications, pharmacies registered with the U.S. Drug Enforcement Administration must keep detailed, accurate records of controlled substances from the moment they arrive until the moment they are dispensed. That includes invoices and order forms, prescription records and periodic physical inventories that count what is on the shelves. Significant losses or thefts must be reported to the DEA.
Those records are the main tool regulators and pharmacy owners use to detect diversion. When the numbers in the books do not match the number of pills on hand, it can be an early warning sign that medication is going missing. That is why falsifying inventory counts is treated as a serious offense in its own right, separate from the taking of the drugs themselves.
Understanding Drug Diversion by Health Workers
Drug diversion is the term used when prescription medications are moved out of legitimate channels for unauthorized use. In health care settings, it can involve pharmacists, technicians, nurses or other workers who have access to controlled substances as part of their jobs.
Diversion by health care workers poses risks on several fronts. Patients may receive fewer pills than prescribed, and pharmacies may face regulatory penalties and financial losses. Workers who divert drugs for their own use may be struggling with substance use disorders that impair their judgment on the job. For these reasons, hospitals and pharmacies increasingly use automated dispensing systems, regular audits and data analysis to catch irregular patterns.
Alabama, like much of the country, has been hit hard by the opioid crisis. The state has historically had one of the highest opioid prescribing rates in the nation, and state and federal agencies have stepped up efforts to tighten oversight of how these medications are prescribed, stored and dispensed.
How Pharmacies Try to Prevent Diversion
Pharmacy owners and managers have a range of safeguards available to catch problems early. Common practices recommended by pharmacy organizations and regulators include:
- Perpetual inventories: Keeping a running count of high-risk medications that is updated with every order received and every prescription filled, so discrepancies show up quickly.
- Frequent spot counts: Counting stock of commonly diverted drugs on a regular schedule, sometimes without advance notice.
- Separation of duties: Making sure the same employee is not responsible for ordering, receiving, counting and reconciling controlled substances.
- Two-person verification: Requiring a second staff member to confirm counts when controlled drugs are received or when inventory is adjusted.
- Data monitoring: Reviewing purchasing and dispensing patterns for unusual spikes or unexplained adjustments.
- Secure storage and cameras: Limiting physical access to controlled substances and using video surveillance in areas where they are stored and dispensed.
Patients can play a role as well. Pharmacists generally encourage customers to count their pills when they pick up a prescription for a controlled medication and to raise any shortage with the pharmacy right away.
How the Federal Case Moves Forward
A federal indictment is issued by a grand jury, a panel of citizens who hear evidence presented by prosecutors and decide whether there is probable cause to believe a crime was committed. Grand jury proceedings are secret, and defendants do not present their side at that stage.
After an indictment is filed, defendants typically make an initial appearance before a federal magistrate judge, where they are told of the charges and their rights, and conditions of release are addressed. At an arraignment, defendants enter a plea. The case then moves through a period of evidence exchange and pretrial motions, and it may be resolved through a plea agreement, a dismissal or a trial before a jury.
If a defendant is convicted, a federal judge determines the sentence after considering the federal sentencing guidelines, the specific facts of the case and the defendant’s history. No upcoming court dates for either defendant were listed in the information released so far.
The Southern District of Alabama
The U.S. District Court for the Southern District of Alabama is based in Mobile and also holds court in Selma. It covers 13 counties in southwest Alabama, including Mobile and Baldwin counties. Federal prosecutors in the district, part of the U.S. Department of Justice, handle cases ranging from drug trafficking and firearms offenses to health care fraud and public corruption.
Where to Find Help
Anyone struggling with misuse of prescription opioids, stimulants or sedatives can get confidential help. The national helpline run by the Substance Abuse and Mental Health Services Administration, at 1-800-662-4357, is free and available around the clock, and it can connect callers with treatment options in their area. The 988 Suicide and Crisis Lifeline is also available by call or text.
Pharmacists and pharmacy technicians who are dealing with substance use problems may also be able to seek help through confidential professional recovery programs, which are designed to support treatment while protecting patient safety.
Unused prescription medications at home can be dropped off at many pharmacies and law enforcement agencies that host take-back boxes, which helps keep drugs from being misused. The DEA also holds national prescription drug take-back days twice a year.
